Rigatelli Gianluca, Zuin Marco, Vassilev Dobrin, Dinh Huy, Giatti Sara, Carraro Mauro, Zanon Francesco, Roncon Loris, Dung Ho Thuong
Cardiovascular Diagnosis and Endoluminal Interventions, Rovigo General Hospital, Rovigo, Italy.
Santa Maria della Misericordia Hospital, Viale Tre Martiri 140, 45100, Rovigo, Italy.
Int J Cardiovasc Imaging. 2019 Feb;35(2):207-214. doi: 10.1007/s10554-018-1497-8. Epub 2018 Nov 16.
To assess the procedural performance and 3-years outcomes of unprotected complex bifurcation Left Main (LM) stenting using either Culotte or the novel nano-crush techniques, consisting in the use of two ultra-thin strut stents with a 1-ring stent crushed into the LM. We analysed the records of patients with complex distal/bifurcation LM disease and contraindications and/or refusal of bypass surgery, who from 1 January 2014 to 1 November 2017, received at operators' discretion LM double stenting by means of nano-crush technique using Orsiro (Biotronik Inc, Bulack, Switzerland) or Onyx (Medtronic Inc, Galway, Ireland) stents or Culotte stenting using same stent platforms. Among 65 patients (28 females, mean age 77.2 ± 6.2 years), 32 received nano-crush while 33 patients received Culotte technique. Mean angles between left anterior descending coronary artery and left circumflex was 63.6 ± 21.3°. Post-operative success was achieved in 100% of cases. Nano-crush patients showed lower contrast medium volume and X-ray exposure, shorter fluoroscopy and procedural times compared to Culotte patients group. At a mean follow-up of 27.4 ± 10.8 months, clinical-driven target lesion revascularization, myocardial infarction and cardiovascular death were 0 versus 4/33 (12.1%, p = 0.04), 1/32 (3.1%) versus 6/33 (18.1%, p = 0.03) and 2/32 (6.2%) versus 8/33 (24.2%, p = 0.04) in nano-crush versus Culotte patients, respectively. In this single center study, the nano-crush technique was associated with less use of contrast, less procedural time and less X-ray exposure compared to the culotte technique for the treatment of unprotected left main bifurcation lesions.
为评估使用Culotte技术或新型纳米挤压技术进行无保护复杂分叉左主干(LM)支架置入术的手术操作情况及3年预后,新型纳米挤压技术是指使用两个超薄支柱支架,将一个单环支架挤压至左主干。我们分析了患有复杂远端/分叉左主干疾病且有禁忌证和/或拒绝搭桥手术的患者记录,这些患者在2014年1月1日至2017年11月1日期间,由术者酌情决定采用纳米挤压技术使用Orsiro(百多力公司,德国柏林)或Onyx(美敦力公司,爱尔兰戈尔韦)支架进行左主干双支架置入,或使用相同支架平台进行Culotte支架置入。在65例患者(28例女性,平均年龄77.2±6.2岁)中,32例接受纳米挤压技术,33例接受Culotte技术。左前降支冠状动脉与左旋支之间的平均夹角为63.6±21.3°。所有病例术后均获得成功。与Culotte技术患者组相比,纳米挤压技术患者的造影剂用量和X线暴露量更低,透视时间和手术时间更短。平均随访27.4±10.8个月时,纳米挤压技术组与Culotte技术组相比,临床驱动的靶病变血运重建、心肌梗死和心血管死亡发生率分别为0/32(0%)对4/33(12.1%,p=0.04)、1/32(3.1%)对6/33(18.1%,p=0.03)和2/32(6.2%)对8/33(24.2%,p=0.04)。在这项单中心研究中,与Culotte技术相比,纳米挤压技术在治疗无保护左主干分叉病变时造影剂使用更少、手术时间更短且X线暴露更少。